7455. Effect of School Integrated Pest Management or Classroom Air Filter Purifiers on Asthma Symptoms in Students With Active Asthma: A Randomized Clinical Trial.
作者: Wanda Phipatanakul.;Petros Koutrakis.;Brent A Coull.;Carter R Petty.;Jonathan M Gaffin.;William J Sheehan.;Peggy S Lai.;Lisa M Bartnikas.;Choong-Min Kang.;Jack M Wolfson.;Mihail Samnaliev.;Amparito Cunningham.;Sachin N Baxi.;Perdita Permaul.;Marissa Hauptman.;Michelle Trivedi.;Margee Louisias.;Liming Liang.;Peter S Thorne.;Nervana Metwali.;Gary Adamkiewicz.;Elliot Israel.;Andrea A Baccarelli.;Diane R Gold.; .
来源: JAMA. 2021年326卷9期839-850页
School and classroom allergens and particles are associated with asthma morbidity, but the benefit of environmental remediation is not known.
7457. Pancreatic Cancer: A Review.
Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer, with approximately 60 430 new diagnoses expected in 2021 in the US. The incidence of PDAC is increasing by 0.5% to 1.0% per year, and it is projected to become the second-leading cause of cancer-related mortality by 2030.
7458. Effect of Slower vs Faster Intravenous Fluid Bolus Rates on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial.
作者: Fernando G Zampieri.;Flávia R Machado.;Rodrigo S Biondi.;Flávio G R Freitas.;Viviane C Veiga.;Rodrigo C Figueiredo.;Wilson J Lovato.;Cristina P Amêndola.;Murillo S C Assunção.;Ary Serpa-Neto.;Jorge L R Paranhos.;José Andrade.;Michele M G Godoy.;Edson Romano.;Felipe Dal Pizzol.;Emerson B Silva.;Miqueias M L Silva.;Miriam C V Machado.;Luiz Marcelo S Malbouisson.;Airton L O Manoel.;Marlus M Thompson.;Lanese M Figueiredo.;Rafael M Soares.;Tamiris A Miranda.;Lucas M de Lima.;Eliana V Santucci.;Thiago D Corrêa.;Luciano C P Azevedo.;John A Kellum.;Lucas P Damiani.;Nilton B Silva.;Alexandre B Cavalcanti.; .
来源: JAMA. 2021年326卷9期830-838页
Slower intravenous fluid infusion rates could reduce the formation of tissue edema and organ dysfunction in critically ill patients; however, there are no data to support different infusion rates during fluid challenges for important outcomes such as mortality.
|